Medtronic 2013 Annual Report Download - page 3

Cardiac Rhythm
1 Atrial Fibrillation
2 Slow Heart Rates (Bradycardia) ‡
3 Fast Heart Rates (Tachycardia) ‡
4 Heart Failure ‡
5 Asymptomatic, Irregular Heart Rates ‡
Coronary
6 Coronary Artery Disease
7 Treatment-Resistant Hypertension *
Structural Heart
8 Heart Valve Disease
9 Congenital Heart Disease
Endovascular
10 Peripheral Vascular Disease
11 Aortic Aneurysms
Spinal and Orthopedic
12 Cervical Degenerative Disc Disease †
13 Scoliosis †
14 Degenerative Disc Disease †
15 Spinal Fracture †
16 Lumbar Spinal Stenosis †
17 Tibial Fractures †
18 Orthopedic Trauma †
Ear, Nose, and Throat
19 Sinus Diseases †
20 Thyroid Conditions
21 Otologic Disorders †
22 Sleep-Disordered Breathing
23 Pediatric Conditions †
24 Ménière’s Disease
Neurological
25 Parkinson’s Disease †
26 Essential Tremor †
27 Dystonia † **
28 Hydrocephalus †
29 Obsessive-Compulsive Disorder † **
30 Severe Spasticity associated with Multiple Sclerosis,
Cerebral Palsy, Stroke, and Spinal Cord and Brain Injuries
31 Epilepsy † *
32 Brain Tumors and Other Lesions †
33 Chronic Pain
34 Subdural Hematomas
35 Cranial Trauma †
Urological/Urogynecological and Gastroenterological
36 Overactive Bladder and Urinary Retention
37 Nausea and Vomiting associated with Gastroparesis **
38 Fecal Incontinence
Diabetes
39 Diabetes
40 Inpatient Dsyglycemia*
* Not approved for commercial distribution in the U.S.
** The Medtronic therapy for this disorder is available in the U.S. through a
Humanitarian Device Exemption. The effectiveness of the therapy for this
disorder has not been demonstrated.
† In addition to devices that treat these conditions, we offer Image-Guided
Navigation Surgical Systems to help surgeons.
‡ Remote Monitoring available with select cardiac devices for clinicians to follow
patients and their implanted cardiac devices remotely, eliminating the need
for some in-office visits.
Our Therapies
Chronic disease is the leading cause of mortality worldwide and a signicant nancial burden on society.
Our products, therapies, and surgical technologies are used to treat many chronic conditions to help
improve quality of life and advance healthcare.
We also oer advanced energy electrosurgical
instruments indicated for use in orthopedic, spinal,
thoracic, reconstructive plastic, surgical oncology, ear,
nose, and throat (ENT), and general surgery procedures.
Our Mission
Contribuire al benessere umano
applicando l’ingegneria biomedica
alla ricerca, alla progettazione,
alla produzione e alla vendita di
strumenti o apparecchi che eliminano
il dolore, ridonano la salute e
prolungano qualitativamente la vita.
Contribuir al bienestar humano mediante la aplicación
de ingeniería biomédica en la investigación, diseño,
fabricación y venta de dispositivos o aparatos que alivian
el dolor, restauran la salud y prolongan la vida.
Contribuer au bien-être de l’homme
en appliquant les principes de
l’ingénierie biomédicale à la recherche,
à la conception, à la fabrication et
à la distribution de matériels ou
d’appareillages qui soulagent la douleur,
rétablissent la santé et prolongent la vie.
Einen Beitrag zum Wohle der
Menschen zu leisten durch
angewandte biomedizinische
Technik zur Rehabilitation,
Lebensverlängerung,
Schmerzlinderung und
Steigerung der Lebensqualität.
To contribute to human welfare by application of biomedical engineering
in the research, design, manufacture, and sale of instruments or
appliances that alleviate pain, restore health, and extend life.
To read the Medtronic Mission in its entirety, go to medtronic.com
75732me_cover.indd 2 6/28/13 3:48 PM
26 27
25 28
31 32
34 29
About Medtronic 21
23
22
19
24
35
Medtronic is the global leader in medical technology, oering an
unprecedented breadth and depth of innovative products, therapies, 12 20
and services to fulll our Mission of alleviating pain, restoring health,
and extending life. In the past year, more than 9 million people
worldwide relied on our therapies, which treat many conditions
9
1
2
including cardiac and vascular diseases, diabetes, and 8 3
neurological and spinal conditions. 6
5
4
With a global reach that extends to more than
140 countries, we have a deep understanding 15
13
of many universal healthcare challenges. We are 30
using our experience, extensive partnerships, 37 11
and the passion of more than 46,000 employees 39 33
16
to help transform healthcare worldwide by 7 7
improving outcomes, expanding access, 14
and enhancing value.
36 18
Medtronic is headquartered in 38
Minneapolis, Minnesota, U.S., and
is publicly traded on the New York
Stock Exchange under the ticker
symbol MDT. 40
10
Our Mission
To contribute to human welfare by
application of biomedical engineering
17
to alleviate pain, restore health, and
extend life.
Pictured on the front: Cheon Young-Mi and
her daughter Jeong Hye-Joo in Jinju City, Korea.
Cheon Young-Mi’s cervical dystonia was treated
with Medtronic Deep Brain Stimulation Therapy.**